| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0014-5793(00)01204-7 |
| P698 | PubMed publication ID | 10692569 |
| P2093 | author name string | Müller M | |
| Beer JH | |||
| Haeberli A | |||
| Büchi L | |||
| Woodtli K | |||
| P2860 | cites work | Reassessment of Ellman's reagent | Q28274979 |
| Erythrocytes with covalently bound fibrinogen as a cellular replacement for the treatment of thrombocytopenia | Q33365111 | ||
| Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions | Q35597837 | ||
| Preparation and anti-HIV activity of O-acylated heparin and dermatan sulfate derivatives with low anticoagulant effect | Q56763526 | ||
| Synthesis of a N′-Alkylamine Anticoagulant Active Low-Molecular-Mass Heparin for Radioactive and Fluorescent Labeling | Q57563874 | ||
| Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin | Q57696124 | ||
| The separation of active and inactive forms of heparin | Q67447965 | ||
| Molecular mass determination of low-molecular-mass heparins. Application of wide collection angle measurements of light scattering using a high-performance gel permeation chromatographic system equipped with a low-angle laser light-scattering photom | Q70474598 | ||
| Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association | Q72285055 | ||
| P433 | issue | 2-3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 115-119 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Preparation and characterization of 'heparinocytes': erythrocytes with covalently bound low molecular weight heparin | |
| P478 | volume | 468 |
| Q26801300 | Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier |
| Q37700751 | Drug delivery by red blood cells: vascular carriers designed by mother nature |
| Q38972974 | Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond |
| Q38218799 | Erythrocytes-based synthetic delivery systems: transition from conventional to novel engineering strategies |
| Q93087990 | Red Blood Cell Membrane Processing for Biomedical Applications |
Search more.